Health Headline

FDA approves Boehringer Ingelheim


Associated Press

INGELHEIM, Germany--(BUSINESS WIRE)--May 26, 2015--Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto? Respimat R (tiotropium bromide and olodaterol)...full story
updated 2015-05-26 09:01 PM
The Health Gallery
Member Services »
Advertisement »
HOME |  WORLD |  Politics |  Business |  Sports |  TAIWAN |  Technology |  Health |  Society |  OPINION
  • Taiwan News  ©  2015 All Rights Reserved.